It is possible that p53 complements anti-cancer and anti-aging effects of rapamycin because p53 inhibits the mTORC1 pathway through AMPK (5′-adenosine monophosphate-activated kinase) phosphorylation of the TSC1/2 complex (92,102). This evidence concerns the gene TP53 and cancer.